Table 2. LRP Expression, Prognostic... | American Society of Hematology

Table 2.

LRP Expression, Prognostic Factors, and Clinical Outcome

Parameter	ALL Patients					MP Treated Patients					IDM/HDM Treated Patients
Parameter	No.	Response (%)	P-Value^*	Median Survival (mo)	P-Value	No.	Response (%)	P-Value^*	Median Survival (mo)	P-Value	No.	Response (%)	P-Value^*	Median Survival (mo)	P-Value
Total	70	59				38	37				32	84
LRP (%)
<10	37	68	.06	54	<.002	21	52	<.05	40	<.001	16	88	.29	69	.36
≥10	33	48		28		17	18		22		16	81		nr
B₂M
<4 mg/L	41	63	.49	46		20	35	.8	38	<.17	21	90	.48	69	.82
≥4 mg/L	29	55		33	.22	18	39		28		11	82		43
LI%^†
<2	41	63	.68	28	<.04	18	39	.3	28	.1	23	83	.31	69	.87
≥2	19	58		nr		10	20		nr		9	100		76
LDH^†
<300 μ/L	42	55	.66	40	<.01	24	33	.8	38	.0001	19	83	.79	69	.97
≥300 μ/L	15	66		30		7	29		11		8	88		46

Parameter	ALL Patients					MP Treated Patients					IDM/HDM Treated Patients
Parameter	No.	Response (%)	P-Value^*	Median Survival (mo)	P-Value	No.	Response (%)	P-Value^*	Median Survival (mo)	P-Value	No.	Response (%)	P-Value^*	Median Survival (mo)	P-Value
Total	70	59				38	37				32	84
LRP (%)
<10	37	68	.06	54	<.002	21	52	<.05	40	<.001	16	88	.29	69	.36
≥10	33	48		28		17	18		22		16	81		nr
B₂M
<4 mg/L	41	63	.49	46		20	35	.8	38	<.17	21	90	.48	69	.82
≥4 mg/L	29	55		33	.22	18	39		28		11	82		43
LI%^†
<2	41	63	.68	28	<.04	18	39	.3	28	.1	23	83	.31	69	.87
≥2	19	58		nr		10	20		nr		9	100		76
LDH^†
<300 μ/L	42	55	.66	40	<.01	24	33	.8	38	.0001	19	83	.79	69	.97
≥300 μ/L	15	66		30		7	29		11		8	88		46

Abbreviation: nr, not reached.

By chi-squared test.

Data were not available from all patients.